Cargando…
Ocrelizumab does not impair B- and T-cell responses to primary VZV infection in a patient with MS
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7051194/ https://www.ncbi.nlm.nih.gov/pubmed/32098867 http://dx.doi.org/10.1212/NXI.0000000000000695 |
_version_ | 1783502727646543872 |
---|---|
author | Novi, Giovanni Ivaldi, Federico Sbragia, Elvira Mikulska, Malgorzata Pesce, Giampaola Inglese, Matilde Kerlero de Rosbo, Nicole Uccelli, Antonio |
author_facet | Novi, Giovanni Ivaldi, Federico Sbragia, Elvira Mikulska, Malgorzata Pesce, Giampaola Inglese, Matilde Kerlero de Rosbo, Nicole Uccelli, Antonio |
author_sort | Novi, Giovanni |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7051194 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-70511942020-03-13 Ocrelizumab does not impair B- and T-cell responses to primary VZV infection in a patient with MS Novi, Giovanni Ivaldi, Federico Sbragia, Elvira Mikulska, Malgorzata Pesce, Giampaola Inglese, Matilde Kerlero de Rosbo, Nicole Uccelli, Antonio Neurol Neuroimmunol Neuroinflamm Clinical/Scientific Notes Lippincott Williams & Wilkins 2020-02-25 /pmc/articles/PMC7051194/ /pubmed/32098867 http://dx.doi.org/10.1212/NXI.0000000000000695 Text en Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Clinical/Scientific Notes Novi, Giovanni Ivaldi, Federico Sbragia, Elvira Mikulska, Malgorzata Pesce, Giampaola Inglese, Matilde Kerlero de Rosbo, Nicole Uccelli, Antonio Ocrelizumab does not impair B- and T-cell responses to primary VZV infection in a patient with MS |
title | Ocrelizumab does not impair B- and T-cell responses to primary VZV infection in a patient with MS |
title_full | Ocrelizumab does not impair B- and T-cell responses to primary VZV infection in a patient with MS |
title_fullStr | Ocrelizumab does not impair B- and T-cell responses to primary VZV infection in a patient with MS |
title_full_unstemmed | Ocrelizumab does not impair B- and T-cell responses to primary VZV infection in a patient with MS |
title_short | Ocrelizumab does not impair B- and T-cell responses to primary VZV infection in a patient with MS |
title_sort | ocrelizumab does not impair b- and t-cell responses to primary vzv infection in a patient with ms |
topic | Clinical/Scientific Notes |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7051194/ https://www.ncbi.nlm.nih.gov/pubmed/32098867 http://dx.doi.org/10.1212/NXI.0000000000000695 |
work_keys_str_mv | AT novigiovanni ocrelizumabdoesnotimpairbandtcellresponsestoprimaryvzvinfectioninapatientwithms AT ivaldifederico ocrelizumabdoesnotimpairbandtcellresponsestoprimaryvzvinfectioninapatientwithms AT sbragiaelvira ocrelizumabdoesnotimpairbandtcellresponsestoprimaryvzvinfectioninapatientwithms AT mikulskamalgorzata ocrelizumabdoesnotimpairbandtcellresponsestoprimaryvzvinfectioninapatientwithms AT pescegiampaola ocrelizumabdoesnotimpairbandtcellresponsestoprimaryvzvinfectioninapatientwithms AT inglesematilde ocrelizumabdoesnotimpairbandtcellresponsestoprimaryvzvinfectioninapatientwithms AT kerleroderosbonicole ocrelizumabdoesnotimpairbandtcellresponsestoprimaryvzvinfectioninapatientwithms AT uccelliantonio ocrelizumabdoesnotimpairbandtcellresponsestoprimaryvzvinfectioninapatientwithms |